Substance / Medication

Cefotaxime

Overview

Active Ingredient
cefotaxime
RxNorm CUI
2186

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

25 trials linked to this intervention

25
Total Trials
4
Recruiting
7
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae.
Diricks Margo, Petersen Sabine, Bartels Lennart et al. · Genome Med · 2024
PMID: 39633433Meta-AnalysisFull text (PMC)
ROLE OF PRE-CESAREAN SECTION CEFOTAXIME IN AMELIORATED POST-CESAREAN COMPLICATION.
Jawad Mahmood J, Hassan Saif M, Obaid Ahmed Kareem et al. · Wiad Lek · 2022
PMID: 35633354RCT
Continuous versus intermittent infusion of cefotaxime in critically ill patients: a randomized controlled trial comparing plasma concentrations.
Aardema Heleen, Bult Wouter, van Hateren Kai et al. · J Antimicrob Chemother · 2020
PMID: 31697336RCT
Population Pharmacokinetic Model to Optimize Cefotaxime Dosing Regimen in Critically Ill Children.
Béranger Agathe, Oualha Mehdi, Urien Saïk et al. · Clin Pharmacokinet · 2018
PMID: 28980166RCT
Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis.
Badawy Ahmed Abouelkhair, Zaher Tarik Ibrahim, Sharaf Samar Mahmoud et al. · World J Gastroenterol · 2013
PMID: 23483064RCTFull text (PMC)
Cefotaxime-heparin lock prophylaxis against hemodialysis catheter-related sepsis among Staphylococcus aureus nasal carriers.
Saxena Anil K, Panhotra Bodh R, Al-hafiz Abdul Aziz et al. · Saudi J Kidney Dis Transpl · 2012
PMID: 22805387RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Cefotaxime (substance)
SNOMED CT
372704003
UMLS CUI
C0007554
RxNorm CUI
2186

Clinical Data

This intervention maps to 20 entities in the Ltrl knowledge graph.

20
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
25
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.